Publication details

Stanovení metylace genu pro O6-metylguanin DNA metyltransferasu (MGMT) u pacientů s glioblastomem - pilotní studie

Title in English Methylation Status of the MGMT Promoter in Patients with Glioblastoma - pilot study
Authors

FADRUS Pavel LAKOMÝ R. HRSTKA R. LŽIČAŘOVÁ E. ŠLAMPA Pavel

Year of publication 2008
Type Article in Periodical
Magazine / Source Česká a Slovenská Neurologie a Neurochirurgie
MU Faculty or unit

Faculty of Medicine

Citation
Field Neurology, neurosurgery, neurosciences
Keywords MGMT; glioblastoma; therapy
Description Pigenetic silencing of the mgmt (O6-methylguanine-DNA methyltransferase)gene by promoter methylation has been associated with longer overall survival in patients with glioblastoma who, in addition to radiotherapy, received alkylating chemotherapy with carmustineor temozolomide. We found that MGMT promoter methylation is associated with a favorable outcome after temozolomide chemotherapy in patients with newly diagnosed glioblastoma. Our data suggest that the methylation status of the MGMTpromoter may have prognostic value and, in addition, may be a clinically relevant predictor of benefit from temozolomide chemotherapy

You are running an old browser version. We recommend updating your browser to its latest version.

More info